167 results  1 of 9 

1 Combination of the LARS1 Inhibitor, BC-LI-0186 with a MEK1/2 Inhibitor Enhances the Anti-Tumor Effect in Non–Small Cell Lung Cancer
Sang Hoon Lee, Eun Young Kim, Jung Min Han, Gyoonhee Han, Yoon Soo Chang
Cancer Res Treat.2023;55(3):851-864.   Published online 2023 March 20     DOI: http://dx.doi.org/10.4143/crt.2022.1527
      
2 Diagnostic Performance of Endosonography to Detect Mediastinal Lymph Node Metastasis in Patients with Radiological N1 Non–Small Cell Lung Cancer
Bo-Guen Kim, Jong Ho Cho, Sun Hye Shin, Kyungjong Lee, Sang-Won Um, Hojoong Kim, Jhingook Kim, Young Mog Shim, Byeong-Ho Jeong
Cancer Res Treat.2023;55(3):832-840.   Published online 2023 March 2     DOI: http://dx.doi.org/10.4143/crt.2022.1428
      
3 MLL4 Regulates the Progression of Non–Small-Cell Lung Cancer by Regulating the PI3K/AKT/SOX2 Axis
Yang Yang, Rongfang Qiu, Qiaoyou Weng, Ziwei Xu, Jingjing Song, Siyu Zhao, Miaomiao Meng, Dengke Zhang, Chunli Kong, Hailin Wang, Min Xu, Zhongwei Zhao, Jiansong Ji
Cancer Res Treat.2023;55(3):778-803.   Published online 2023 January 26     DOI: http://dx.doi.org/10.4143/crt.2022.1042
      
4 Genomic Characteristics and the Potential Clinical Implications in Oligometastatic Non–Small Cell Lung Cancer
Rongxin Liao, Kehong Chen, Jinjin Li, Hengqiu He, Guangming Yi, Mingfeng Huang, Rongrong Chen, Lu Shen, Xiaoyue Zhang, Zaicheng Xu, Zhenzhou Yang, Yuan Peng
Cancer Res Treat.2023;55(3):814-831.   Published online 2023 January 12     DOI: http://dx.doi.org/10.4143/crt.2022.1315
      
5 Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation–Positive Non–Small Cell Lung Cancer
Jang Ho Lee, Eun Young Kim, Cheol-Kyu Park, Shin Yup Lee, Min Ki Lee, Seong-Hoon Yoon, Jeong Eun Lee, Sang Hoon Lee, Seung Joon Kim, Sung Yong Lee, Jun Hyeok Lim, Tae-Won Jang, Seung Hun Jang, Kye Young Lee, Seung Hyeun Lee, Sei Hoon Yang, Dong Won Park, Chan Kwon Park, Hye Seon Kang, Chang Dong Yeo, Chang-Min Choi, Jae Cheol Lee
Cancer Res Treat.2023;55(1):112-122.   Published online 2022 July 19     DOI: http://dx.doi.org/10.4143/crt.2022.381
      
6 Clinical Efficacy of Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer Patients with Liver Metastases: A Network Meta-Analysis of Nine Randomized Controlled Trials
Qing Yin, Longguo Dai, Ruizhu Sun, Ping Ke, Liya Liu, Bo Jiang
Cancer Res Treat.2022;54(3):803-816.   Published online 2021 October 25     DOI: http://dx.doi.org/10.4143/crt.2021.764
      
7 Comparison of the Predictive Power of a Combination versus Individual Biomarker Testing in Non–Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
Hyojin Kim, Hyun Jung Kwon, Eun Sun Kim, Soohyeon Kwon, Kyoung Jin Suh, Se Hyun Kim, Yu Jung Kim, Jong Seok Lee, Jin-Haeng Chung
Cancer Res Treat.2022;54(2):424-433.   Published online 2021 July 7     DOI: http://dx.doi.org/10.4143/crt.2021.583
      
8 Inhibition of lncRNA KCNQ1OT1 Improves Apoptosis and Chemotherapy Drug Response in Small Cell Lung Cancer by TGF-β1 Mediated Epithelial-to-Mesenchymal Transition
Deyu Li, Qin Tong, Yuane Lian, Zhizhong Chen, Yaru Zhu, Weimei Huang, Yang Wen, Qiongyao Wang, Shumei Liang, Man Li, Jianjing Zheng, Zhenhua Liu, Huanxin Liu, Linlang Guo
Cancer Res Treat.2021;53(4):1042-1056.   Published online 2021 March 9     DOI: http://dx.doi.org/10.4143/crt.2020.1208
      
9 Surgical Impacts of Metastatic Non-small Cell Lung Cancer to the Thoracic and Lumbar Spine
Jong-myung Jung, Seung-Jae Hyun, Ki-Jeong Kim
J Korean Med Sci.2021;36(7):e52.  Published online 2021 February 1     DOI: http://dx.doi.org/10.3346/jkms.2021.36.e52
      
10 The Effect of Epidermal Growth Factor Receptor Mutation on Intracranial Progression-Free Survival of Non-Small Cell Lung Cancer Patients with Brain Metastasis Underwent Gamma Knife Radiosurgery
Seung-Hyeon Yang, Hae Yu Kim, Sun-il Lee, Seong Jin Jin
Brain Tumor Res Treat.2020;8(2):103-108.   Published online 2020 August 10     DOI: http://dx.doi.org/10.14791/btrt.2020.8.e15
      
11 Induction of cytoprotective autophagy by morusin via AMP-activated protein kinase activation in human non-small cell lung cancer cells
Hyun-Ji Park, Shin-Hyung Park
Nutr Res Pract.2020;14(5):478-489.   Published online 2020 July 2     DOI: http://dx.doi.org/10.4162/nrp.2020.14.5.478
      
12 EGFR C797S as a Resistance Mechanism of Lazertinib in Non-small Cell Lung Cancer with EGFR T790M Mutation
Sehhoon Park, Bo Mi Ku, Hyun Ae Jung, Jong-Mu Sun, Jin Seok Ahn, Se-Hoon Lee, Keunchil Park, Myung-Ju Ahn
Cancer Res Treat.2020;52(4):1288-1290.   Published online 2020 June 22     DOI: http://dx.doi.org/10.4143/crt.2020.278
      
13 Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea
Sun Min Lim, Sang-We Kim, Byoung Chul Cho, Jin Hyung Kang, Myung-Ju Ahn, Dong-Wan Kim, Young-Chul Kim, Jin Soo Lee, Jong-Seok Lee, Sung Yong Lee, Keon Uk Park, Ho Jung An, Eun Kyung Cho, Tae Won Jang, Bong-Seog Kim, Joo-Hang Kim, Sung Sook Lee, Im-II Na, Seung Soo Yoo, Ki Hyeong Lee
Cancer Res Treat.2020;52(4):1112-1119.   Published online 2020 May 15     DOI: http://dx.doi.org/10.4143/crt.2020.245
      
14 Current status and future perspectives of liquid biopsy in non-small cell lung cancer
Sunhee Chang, Jae Young Hur, Yoon-La Choi, Chang Hun Lee, Wan Seop Kim
J Pathol Transl Med.2020;54(3):204-212.   Published online 2020 April 15     DOI: http://dx.doi.org/10.4132/jptm.2020.02.27
      
15 Caspase Recruitment Domain Containing Protein 9 Suppresses Non-Small Cell Lung Cancer Proliferation and Invasion via Inhibiting MAPK/p38 Pathway
Linyue Pan, Yuting Tan, Bin Wang, Wenjia Qiu, Yulei Yin, Haiyan Ge, Huili Zhu
Cancer Res Treat.2020;52(3):867-885.   Published online 2020 March 11     DOI: http://dx.doi.org/10.4143/crt.2019.606
      
16 Immunotherapy for Non-small Cell Lung Cancer: Current Landscape and Future Perspectives
Sun Min Lim, Min Hee Hong, Hye Ryun Kim
Immune Netw.2020;20(1):e10.  Published online 2020 February 4     DOI: http://dx.doi.org/10.4110/in.2020.20.e10
      
17 Immunotherapy for Non-small Cell Lung Cancer: Current Landscape and Future Perspectives
Sun Min Lim, Min Hee Hong, Hye Ryun Kim
Immune Netw.2020;20(1):e10.  Published online 2020 January 27     DOI: http://dx.doi.org/10.4110/in.2020.20.e10
      
18 Demographic and Socioeconomic Factors for Renouncing Further Active Therapy for Patients with Brain Metastasis of Non-Small Cell Lung Cancer
Gyuseo Jung, Seok-Hyun Kim, Tae Gyu Kim, Young Zoon Kim
Brain Tumor Res Treat.2019;7(2):112-121.   Published online 2019 October 29     DOI: http://dx.doi.org/10.14791/btrt.2019.7.e35
      
19 Recent Trends in Demographics, Surgery, and Prognosis of Patients with Surgically Resected Lung Cancer in a Single Institution from Korea
Jae Kwang Yun, Han Pil Lee, Geun Dong Lee, Hyeong Ryul Kim, Yong-Hee Kim, Dong Kwan Kim, Seung-Il Park, Sehoon Choi
J Korean Med Sci.2019;34(45):e291.  Published online 2019 October 25     DOI: http://dx.doi.org/10.3346/jkms.2019.34.e291
      
20 Sonic Hedgehog Pathway as the Prognostic Marker in Patients with Extensive Stage Small Cell Lung Cancer
Seungtaek Lim, Sun Min Lim, Min-Ju Kim, Shin Young Park, Joo-Hang Kim
Yonsei Med J.2019;60(10):898-904.   Published online 2019 September 16     DOI: http://dx.doi.org/10.3349/ymj.2019.60.10.898
      

 1 of 9